Open access · OA
via OpenAlex
Mesenchymal Stem Cells for Treating Articular Cartilage Defects and Osteoarthritis
Yu Wang, Mei Yuan, Quanyi Guo, Shibi Lu, Jiang Chen Peng
Cell Transplantation · 2014 · ▲ 86 citations
Abstract
Articular cartilage damage and osteoarthritis are the most common joint diseases. Joints are prone to damage caused by sports injuries or aging, and such damage regularly progresses to more serious joint disorders, including osteoarthritis, which is a degenerative disease characterized by the thinning and eventual wearing out of articular cartilage, ultimately leading to joint destruction. Osteoarthritis affects millions of people worldwide. Current approaches to repair of articular cartilage damage include mosaicplasty, microfracture, and injection of autologous chondrocytes. These treatments relieve pain and improve joint function, but the long-term results are unsatisfactory. The long-term success of cartilage repair depends on development of regenerative methodologies that restore articular cartilage to a near-native state. Two promising approaches are (i) implantation of engineered constructs of mesenchymal stem cell (MSC)-seeded scaffolds, and (ii) delivery of an appropriate population of MSCs by direct intra-articular injection. MSCs may be used as trophic producers of bioactive factors initiating regenerative activities in a defective joint. Current challenges in MSC therapy are the need to overcome current limitations in cartilage cell purity and to in vitro engineer tissue structures exhibiting the required biomechanical properties. This review outlines the current status of MSCs used in cartilage tissue engineering and in cell therapy seeking to repair articular cartilage defects and related problems. MSC-based technologies show promise when used to repair cartilage defects in joints.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3727/096368914x683485
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Wang, Y., Yuan, M., Guo, Q., Lu, S., & Peng, J.C. (2014). Mesenchymal Stem Cells for Treating Articular Cartilage Defects and Osteoarthritis. <em>Cell Transplantation</em>. https://doi.org/10.3727/096368914x683485
Vancouver
Wang Y, Yuan M, Guo Q, Lu S, Peng JC. Mesenchymal Stem Cells for Treating Articular Cartilage Defects and Osteoarthritis. Cell Transplantation. 2014. doi:10.3727/096368914x683485.
BibTeX
@article{yu2014Mesenc,
title = {Mesenchymal Stem Cells for Treating Articular Cartilage Defects and Osteoarthritis},
author = {Yu Wang and Mei Yuan and Quanyi Guo and Shibi Lu and Jiang Chen Peng},
journal = {Cell Transplantation},
year = {2014},
doi = {10.3727/096368914x683485},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PubMed 2009
Preprint · OA
Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy.
BioDrugs 2018
Citation only
Tissue Engineering in Osteoarthritis: Current Status and Prospect of Mesenchymal Stem Cell Therapy
Methods 2015
Open access · CC-BY
Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration
Stem Cell Research & Therapy 2022
Open access · CC-BY
Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review
Mechanisms of Ageing and Development 2021
Open access · CC-BY
Age-related alterations and senescence of mesenchymal stromal cells: Implications for regenerative treatments of bones and joints
PubMed 2002
Preprint